Caloric restriction normalizes bile acid, cholesterol deficiency

Caloric restriction normalizes bile acid, cholesterol deficiency

(HealthDay)—Acute caloric restriction normalizes hepatic bile acid (BA) and cholesterol deficiency that is seen in morbidly obese women, according to a study published online March 6 in the Journal of Internal Medicine.

Sara Straniero, Ph.D., from Karolinska University Hospital in Stockholm, and colleagues monitored 10 morbidly obese women on days zero, three, seven, 14, and 28 after initiating a low-calorie diet. They collected serum and determined liver size and fat content. The results were compared with those from 54 non-obese women who served as controls.

The researchers found that, compared with controls, the obese group had elevated synthesis of both BAs and cholesterol and of BAs and proprotein convertase subtilisin/kexin type 9 (PCSK9) at baseline. BA and cholesterol synthesis and serum BA and PCSK9 levels normalized after three days on the low-calorie diet, while increased. There was no change in fibroblast growth factor 19 and triglyceride levels, and a 10 percent decrease was seen in liver volume.

"The results suggest that hepatic BAs and cholesterol are deficient in morbid obesity," the authors write. "Caloric restriction rapidly counteracts these deficiencies, normalizing BA and and circulating PCSK9 levels, indicating that overproduction of in enlarged peripheral tissues cannot explain this phenotype."

More information: Abstract
Full Text

Journal information: Journal of Internal Medicine

Copyright © 2017 HealthDay. All rights reserved.

Citation: Caloric restriction normalizes bile acid, cholesterol deficiency (2017, March 20) retrieved 16 April 2024 from https://medicalxpress.com/news/2017-03-caloric-restriction-bile-acid-cholesterol.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New lipid-lowering drugs help patients reduce LDL cholesterol

0 shares

Feedback to editors